CompuGroup Medical SE & Co. KGaA

FSX:COP.DE

22.28 (EUR) • At close February 20, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 1,187.6631,129.7391,025.322837.259745.808717.023582.375560.195543.066515.104459.554450.582396.564319.367300.288229.191180.1895.853
Cost of Revenue 888.82171.578154.132124.306114.386132.91690.34494.04390.89690.0369.70175.90874.39258.9861.03149.248-33.898-0.305
Gross Profit 298.843958.161871.19712.953631.422584.107492.031466.152452.17425.074389.853374.674322.172260.387239.257179.943214.0876.158
Gross Profit Ratio 0.2520.8480.850.8520.8470.8150.8450.8320.8330.8250.8480.8320.8120.8150.7970.7851.1881.052
Reseach & Development Expenses 252.164106.2123.681.879.673.418.41321.50116.554003.927000000
General & Administrative Expenses 28.46833.25534.01326.78526.28119.299.62985.37789.64389.59578.03265.63900095.76900
Selling & Marketing Expenses 9.03811.71712.2299.53110.87610.565000000000005.533
SG&A 37.50644.97246.24236.31637.15729.76599.62985.37789.64389.59578.03265.63900095.76905.533
Other Expenses 967.549805.732717.047551.271479.0030.450.4740.5450.971.2051.4180.41285.517227.324214.46162.994119.86-12.502
Operating Expenses 1,005.055850.704763.289587.587516.16444.592404.893387.449385.974380.986334.781308.597285.517227.324214.461158.763119.8610.204
Operating Income 155.161125.612108.686119.67112.285136.53383.39676.34664.35442.87256.82865.25536.65533.06324.79612.827.43721.912
Operating Income Ratio 0.1310.1110.1060.1430.1510.190.1430.1360.1190.0830.1240.1450.0920.1040.0830.0560.1523.744
Total Other Income Expenses Net -82.489-19.737-163.579-135.84-11.176-10.764-14.24-4.49-4.2190.848-19.885-17.203-10.976-6.811-6.479-5.819-4.415-12.502
Income Before Tax 72.672106.81697.874110.426107.745128.75165.55674.21362.20444.45535.20848.37425.19826.39118.3176.981-23.0229.41
Income Before Tax Ratio 0.0610.0950.0950.1320.1440.180.1130.1320.1150.0860.0770.1070.0640.0830.0610.03-0.1281.608
Income Tax Expense 25.832.69928.84237.00641.59436.15633.81329.74323.58220.33913.03317.95115.9279.7986.6015.7130.1833.566
Net Income 45.91673.41168.9773.19265.81992.33831.2544.5338.49426.33723.14730.7169.27116.59311.7161.26823.0325.844
Net Income Ratio 0.0390.0650.0670.0870.0880.1290.0540.0790.0710.0510.050.0680.0230.0520.0390.0060.1280.999
EPS 0.881.411.321.361.361.880.630.90.770.530.470.620.190.330.230.0240.460.13
EPS Diluted 0.881.41.31.361.331.850.630.90.770.530.470.620.190.330.230.0240.460.13
EBITDA 215.841231.356216.627194.546175.928182.003113.186124.83116.83101.78190.632106.96275.59667.34261.70749.79352.5931.407
EBITDA Ratio 0.1820.2110.2140.2330.2350.2540.1870.2220.2150.1910.190.2250.1960.2210.2050.2520.0215.366